AIMT
Aimmune Therapeutics
AIMT
AIMT
Delisted
AIMT was delisted on the 12th of October, 2020.
90 hedge funds and large institutions have $771M invested in Aimmune Therapeutics in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 33 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
2% less funds holding
Funds holding: 92 → 90 (-2)
Holders
90
Holding in Top 10
5
Calls
$303K
Puts
–
Top Buyers
| 1 | +$46.5M | |
| 2 | +$43.5M | |
| 3 | +$17.2M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$11.2M |
| 5 |
Credit Agricole
Montrouge Cedex,
France
|
+$8.99M |
Top Sellers
| 1 | -$31.6M | |
| 2 | -$13.9M | |
| 3 | -$5.07M | |
| 4 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$4.12M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$3.39M |